1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment F Alongi, M Rigo, V Figlia, F Cuccia, N Giaj-Levra, L Nicosia, F Ricchetti, ... Radiation Oncology 15, 1-9, 2020 | 107 | 2020 |
Lung metastases treated with stereotactic ablative radiation therapy in oligometastatic colorectal cancer patients: outcomes and prognostic factors after long-term follow-up L Agolli, S Bracci, L Nicosia, M Valeriani, V De Sanctis, MF Osti Clinical colorectal cancer 16 (1), 58-64, 2017 | 83 | 2017 |
Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized … OD Gentilini, E Botteri, C Sangalli, V Galimberti, M Porpiglia, R Agresti, ... JAMA oncology 9 (11), 1557-1564, 2023 | 68 | 2023 |
Metastasis-directed therapy (SBRT) guided by PET-CT 18F-CHOLINE versus PET-CT 68Ga-PSMA in castration-sensitive oligorecurrent prostate cancer: a comparative analysis of … R Mazzola, G Francolini, L Triggiani, G Napoli, F Cuccia, L Nicosia, L Livi, ... Clinical Genitourinary Cancer 19 (3), 230-236, 2021 | 60 | 2021 |
Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: short-term results of a … M Lupattelli, F Matrone, MA Gambacorta, M Osti, G Macchia, E Palazzari, ... Radiation Oncology 12, 1-7, 2017 | 43 | 2017 |
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy F Cuccia, R Mazzola, L Nicosia, V Figlia, N Giaj-Levra, F Ricchetti, M Rigo, ... Radiation Oncology 15, 1-9, 2020 | 42 | 2020 |
Modern radiotherapy in cancer treatment during pregnancy R Mazzola, S Corradini, M Eidemüeller, V Figlia, A Fiorentino, ... Critical Reviews in Oncology/Hematology 136, 13-19, 2019 | 42 | 2019 |
30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease MF Osti, L Agolli, M Valeriani, C Reverberi, S Bracci, L Marinelli, ... Lung Cancer 122, 165-170, 2018 | 39 | 2018 |
Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy L Nicosia, G Sicignano, M Rigo, V Figlia, F Cuccia, A De Simone, ... Acta Oncologica 60 (2), 215-221, 2021 | 35 | 2021 |
A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: A monocentric prospective … E Bertocchi, G Barugola, L Nicosia, R Mazzola, F Ricchetti, P Dell’Abate, ... La radiologia medica 125, 990-998, 2020 | 31 | 2020 |
Potential role of single nucleotide polymorphisms of XRCC1, XRCC3, and RAD51 in predicting acute toxicity in rectal cancer patients treated with preoperative radiochemotherapy MF Osti, L Nicosia, L Agolli, G Gentile, T Falco, S Bracci, F Di Nardo, ... American journal of clinical oncology 40 (6), 535-542, 2017 | 31 | 2017 |
Stereotactic ablative body radiotherapy (SABR) in pulmonary oligometastatic/oligorecurrent non-small cell lung cancer patients: a new therapeutic approach L Agolli, M Valeriani, L Nicosia, S Bracci, V De Sanctis, G Minniti, ... Anticancer research 35 (11), 6239-6245, 2015 | 31 | 2015 |
Rectal spacer hydrogel in 1.5 T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes F Alongi, M Rigo, V Figlia, F Cuccia, N Giaj-Levra, L Nicosia, F Ricchetti, ... The British Journal of Radiology 94 (1117), 20200848, 2021 | 29 | 2021 |
Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes R Mazzola, V Figlia, M Rigo, F Cuccia, F Ricchetti, N Giaj-Levra, L Nicosia, ... Journal of Cancer Research and Clinical Oncology 146, 2379-2397, 2020 | 29 | 2020 |
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis N Luca, F Ciro, R Mazzola, F Davide, M Rigo, S Corradini, A Filippo, ... Strahlentherapie und Onkologie 196 (3), 213-221, 2020 | 29 | 2020 |
Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low-and favorable intermediate-risk prostate cancer patients L Nicosia, R Mazzola, M Rigo, V Figlia, N Giaj-Levra, G Napoli, F Ricchetti, ... Journal of Cancer Research and Clinical Oncology 145, 2547-2554, 2019 | 29 | 2019 |
Malignant phyllodes tumor of the breast: a systematic review G Lissidini, A Mulè, A Santoro, G Papa, L Nicosia, E Cassano, AA Ashoor, ... Pathologica 114 (2), 111, 2022 | 26 | 2022 |
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study L Nicosia, D Franceschini, F Perrone-Congedi, F Casamassima, ... Radiotherapy and Oncology 166, 92-99, 2022 | 26 | 2022 |
Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study A Bozzini, L Nicosia, G Pruneri, P Maisonneuve, L Meneghetti, G Renne, ... Breast Cancer Research and Treatment 184, 723-731, 2020 | 26 | 2020 |
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis L Nicosia, V Figlia, R Mazzola, G Napoli, N Giaj-Levra, F Ricchetti, M Rigo, ... Clinical & experimental metastasis 37 (1), 77-83, 2020 | 25 | 2020 |